CMND — Clearmind Medicine Balance Sheet
0.000.00%
Last trade - 00:00
- CA$5.96m
- -CA$1.47m
2019 October 31st | 2020 October 31st | 2021 October 31st | R2022 October 31st | 2023 October 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | Interim Report | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | fx Final | fx Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.001 | 0.248 | 3.71 | 0.323 | 5.51 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.002 | 0.002 | 0.13 | 0.098 | 0.24 |
Prepaid Expenses | |||||
Total Current Assets | 0.003 | 0.25 | 3.97 | 0.435 | 5.79 |
Net Property, Plant And Equipment | 0.133 | 0.135 | 0.017 | 0.049 | 0.002 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 0.136 | 0.385 | 4.16 | 0.826 | 5.95 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.034 | 0.01 | 0.288 | 1.93 | 4.97 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.034 | 0.01 | 0.288 | 1.93 | 4.97 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 0.102 | 0.375 | 3.88 | -1.11 | 0.983 |
Total Liabilities & Shareholders' Equity | 0.136 | 0.385 | 4.16 | 0.826 | 5.95 |
Total Common Shares Outstanding |